Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study

Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study

Abstract Background Community-acquired pneumonia (CAP) is a major cause of death worldwide and occurs with variable severity. There are few studies focused on the expression of soluble urokinase-type plasminogen activator receptor (suPAR) and syndecan-4 in patients with CAP. Methods A prospective, m...

Full description

Bibliographic Details
Main Authors: Qiongzhen Luo, Pu Ning, Yali Zheng, Ying Shang, Bing Zhou, Zhancheng Gao
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Critical Care
Subjects:
suPAR
Syndecan-4
Community acquired pneumonia
Severity
Mortality
Online Access:http://link.springer.com/article/10.1186/s13054-018-1943-y

Internet

http://link.springer.com/article/10.1186/s13054-018-1943-y

Similar Items